Exposure of Orbital Implants Wrapped With Polyester-Urethane After Enucleation for Advanced Retinoblastoma

Purpose: Enucleation is the main form of treatment for advanced retinoblastoma. The major complication of this procedure is orbital implant exposure. Different implants and wrapping materials are currently in use. The aim of the current study was to analyze the complications associated with the use of polyester-urethane, an artificial dura substitute, as a wrapping material for enucleation in advanced retinoblastoma. Methods: A retrospective review of 32 cases (28 patients), who were treated with enucleation for advanced retinoblastoma, was performed. The age of the patients ranged between 3 months and 6.7 years (median, 19 months). Additional chemotherapy was administered in 12 cases. The removed eyeball was replaced either with a silicone implant and polyester-urethane wrapping (13 cases) or hydroxyapatite, silicone-hydroxyapatite, or polyethylene implants without additional wrappings (19 cases). The follow-up period ranged from 7 months to 5.9 years (median, 22.4 months). Statistical analysis was performed using the Kaplan-Meier method. Results: Single or multiple exposures occurred in 22% of cases (7/32). There were 6 exposures (46%, 6/13) in the group with polyester-urethane wrapping compared with only 1 exposure (5%, 1/19) in the implants without wrapping. This difference was statistically significant (p = 0.0236). None of the other analyzed factors (additional chemotherapy, surgeon, age of the patient, or size of the implant) demonstrated a significant correlation to implant exposures. Conclusions: Wrapping of orbital implants with polyester-urethane resulted in a high rate of implant exposures after enucleation for advanced retinoblastoma. In this series, the best results were achieved with integrated implants without additional wrapping.

[1]  S. Honavar,et al.  Thermochemotherapy in hereditary retinoblastoma , 2003, The British journal of ophthalmology.

[2]  M. O'Keefe,et al.  Hydroxyapatite orbital implant exposure in children. , 2003, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[3]  S. Kaltreider,et al.  Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology. , 2003, Ophthalmology.

[4]  C. Shields,et al.  Trends in the management of retinoblastoma: evaluation of 1,196 consecutive eyes during 1974 to 2001. , 2003, Journal of pediatric ophthalmology and strabismus.

[5]  J. Godard,et al.  [Use of polyester urethane (Neuro-Patch) as a dural substitute. Prospective study of 70 cases]. , 2003, Neuro-Chirurgie.

[6]  J. Mehta,et al.  The sclera, the prion, and the ophthalmologist , 2002, The British journal of ophthalmology.

[7]  H. Tawfik,et al.  Orbital implants in postenucleation retinoblastoma. , 2001, Ophthalmology.

[8]  T. Sato,et al.  Creutzfeldt–Jakob disease associated with cadaveric dura mater grafts in Japan , 2000, Neurology.

[9]  L. Atchaneeyasakul,et al.  Discussion by A. Linn Murphree, MD La-ongsri Atchaneeyasakul, MD , 2000 .

[10]  N. Davies,et al.  Exposure of primary orbital implants in postenucleation retinoblastoma patients. , 2000, Ophthalmology.

[11]  P. Mullaney,et al.  Porous polyethylene orbital implant in patients with retinoblastoma. , 1998, Ophthalmology.

[12]  T. Sato.  Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts -- Japan, January 1979-May 1996. , 1997, MMWR. Morbidity and mortality weekly report.

[13]  C. Chui,et al.  Effect of ocular implants of different materials on the dosimetry of external beam radiation therapy. , 1995, International journal of radiation oncology, biology, physics.

[14]  R. Guthoff,et al.  [Prevention of postenucleation syndrome: the hydroxylapatite silicone implant. Preliminary experimental studies and initial clinical experiences]. , 1995, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[15]  C. Shields,et al.  Enucleation technique for children with retinoblastoma. , 1992, Journal of pediatric ophthalmology and strabismus.

[16]  C. Shields,et al.  Hydroxyapatite orbital implant after enucleation. Experience with initial 100 consecutive cases. , 1992, Archives of ophthalmology.

[17]  E. Halperin,et al.  Influence of coralline hydroxyapatite used as an ocular implant on the dose distribution of external beam photon radiation therapy. , 1992, Ophthalmology.

[18]  C. Shields,et al.  Current treatment of retinoblastoma. , 1989, Transactions - Pennsylvania Academy of Ophthalmology and Otolaryngology.